Synucleinopathies, a group of progressive neurological disorders that includes Parkinson’s disease, dementia with Lewy bodies and multiple system atrophy, may...

Parkinson’s disease has long been understood as the product of a complicated interplay between inherited susceptibility and environmental stress. Yet...

Parkinson’s disease may begin changing the body’s molecular machinery long before tremor, stiffness, or slowed movement become visible. A study...

Researchers at Weill Cornell Medicine have revealed how LRRK2, a protein strongly associated with Parkinson’s disease, switches between inactive and...

A molecular switch hidden in RNA is emerging as a crucial link between environmental pollution, brain development and neurodegenerative disease,...

Scientists have produced the first complete, end-to-end genome sequence of the common marmoset, creating a high-resolution genetic reference for one...

Parkinson’s disease may begin damaging cells long before tremors, stiffness, and slowed movement become visible. A new study published in...

A new artificial intelligence system has identified a pair of potential disease-modifying targets in Parkinson’s disease, then helped guide experiments...

Parkinson’s disease may leave a molecular trace in one of the body’s most overlooked fluids: tears. A study by Acera,...

Parkinson’s disease may leave a visible signature in the laboratory long before its most familiar symptoms become obvious. In a...